Jafron Biomedical Co.,Ltd.’s Net Profit Dropped 41.6% in First Quarter of 2023

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 195.3 million yuan in the first quarter of 2023, down 41.6% year-on-year.

Meanwhile, the company posted 572.6 million yuan in revenue, down 17.9% year-on-year.

At the end of the reporting period, it had 6 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 36.5%.